← SynDRA
SAREDUTANT
SynDRA canonical compound SYN0003146 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | TACR2 |
| Mechanism of action | neurokinin receptor antagonist |
| Indication | depression |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- TACR2 ANTAGONIST
- Neurokinin 2 receptor antagonist
- neurokinin receptor antagonist
Cross-references
Synonyms
- SR-48968
- CHEMBL308148
- SR 48968C
- [<SUP>3</SUP>H]SAREDUTANT
- SR 48968
- SR48968
- UNII-720U2QK8I5
- (S)-N-Methyl-N(4-(4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl)butyl)benzamide
- SR48968C
- 720U2QK8I5
- N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
- N-((S)-beta-(2-(4-Acetamido-4-phenylpiperidino)ethyl)-3,4-dichlorophenethyl)-N-methylbenzamide
- [3H]saredutant
- SR-48968C
- Benzamide, N-((2S)-4-(4-(acetylamino)-4-phenyl-1-piperidinyl)-2-(3,4-dichlorophenyl)butyl)-N-methyl-
- SR-48965
- SR-489686
- saredutantum
- RefChem:931296
- DTXCID2084414
- Saredutant [INN]
- SR 48968; SR 48968C
- [3H]SR48968
- [3H]-SR49868
- [3H]SR48,968
- SAREDUTANT [WHO-DD]
- SCHEMBL185911
- GTPL2111
- GTPL3481
- orb1706664
- SCHEMBL29371280
- CHEBI:233291
- BDBM50071484
- PDSP1_000659
- PDSP2_000650
- AKOS040742611
- EBC-521172
- DA-67410
- MS-30095
Look up SAREDUTANT in the interactive SynDRA portal →